NYSE:XYLMachinery
Xylem Sharpens 80 20 Focus As Evoqua Deal Closes And Dividend Rises
Xylem (NYSE:XYL) has completed the integration of its US$7.5b Evoqua acquisition ahead of schedule.
The company is launching Phase 2 of its transformation plan with an "80/20" focus on higher quality earnings.
Xylem plans to exit certain lower margin and selected international operations, including a retreat from the Chinese market.
The board approved an 8% increase in the quarterly dividend, reflecting confidence in financial resilience.
Xylem, trading at $126.77, is reshaping its...